Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci189152
Affiliations:
43
Authors:
47
Go to article
Institutions Authors Share
University of Cologne (UoC), Germany
13.000000
13.000000
 0.28
University Hospital of Cologne, Germany
9.500000
 0.20
Oslo University Hospital (OUS), Norway
3.000000
 0.06
The Institute of Cancer Research (ICR), United Kingdom (UK)
2.333333
 0.05
St. Anna Children's Hospital, Austria
2.000000
 0.04
Curie Institute, France
2.000000
 0.04
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands
1.500000
 0.03
Children's Hospital of Philadelphia (CHOP), United States of America (USA)
1.500000
 0.03
Charité - University Medicine Berlin, Germany
1.500000
 0.03
Hopp Children's Cancer Center Heidelberg (KiTZ), Germany
1.200000
 0.03
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany
1.200000
 0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
 0.02
University Hospital Tübingen (UKT), Uni Tübingen, Germany
1.000000
 0.02
Great Ormond Street Hospital for Children (GOSH), United Kingdom (UK)
1.000000
 0.02
Essen University Hospital, Germany
1.000000
 0.02
Medical University of Vienna (MUW), Austria
0.500000
 0.01
Utrecht University (UU), Netherlands
0.500000
 0.01
University of Naples Federico II (UNINA), Italy
0.500000
 0.01
Ceinge - Biotecnologie Avanzate S.C. a r.l., Italy
0.500000
 0.01
University of Pennsylvania (Penn), United States of America (USA)
0.500000
 0.01
The Francis Crick Institute, United Kingdom (UK)
0.333333
 0.01
The Royal Marsden Hospital (Surrey), United Kingdom (UK)
0.333333
 0.01
DKTK Partner Site Berlin, Germany
0.250000
 0.01
Max Delbrück Center for Molecular Medicine (MDC), Germany
0.250000
 0.01
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany
0.200000
 0.00
German Consortium of Translational Cancer Research (DKTK), Germany
0.200000
 0.00
National Center for Tumor Diseases (NCT) Heidelberg, Germany
0.200000
 0.00
Interested in Oncology and Carcinogenesis?